| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:A-420983
CAS:330789-03-2
Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Email: |
info@biorbyt.com |
| Products Intro: |
Product Name:A-420983
CAS:330789-03-2
|
A-420983 manufacturers
- A-420983
-
- $1520.00 / 25mg
-
2025-08-21
- CAS:330789-03-2
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | A-420983 Basic information |
| Product Name: | A-420983 | | Synonyms: | A-420983;A-420983;A 420983;A420983;1H-Indole-2-carboxamide, N-[4-[4-amino-1-[trans-4-(4-methyl-1-piperazinyl)cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl]-1-methyl- | | CAS: | 330789-03-2 | | MF: | C33H39N9O2 | | MW: | 593.72 | | EINECS: | | | Product Categories: | | | Mol File: | 330789-03-2.mol |  |
| | A-420983 Chemical Properties |
| Boiling point | 758.3±60.0 °C(Predicted) | | density | 1.40±0.1 g/cm3(Predicted) | | pka | 13.21±0.70(Predicted) |
| | A-420983 Usage And Synthesis |
| Uses | A-420983 is a potent, orally active inhibitor of Lck and can be used in studies involving animal models of delayed-type hypersensitivity and organ transplant rejection[1]. | | References | [1] Borhani DW, et al. A-420983: a potent, orally active inhibitor of lck with efficacy in a model of transplant rejection. Bioorg Med Chem Lett. 2004;14(10):2613-2616. DOI:10.1016/j.bmcl.2004.02.101 |
| | A-420983 Preparation Products And Raw materials |
|